[4519]中外薬:【製薬】スイスのロシュ傘下がん領域など新薬候補は充実

Yahoo! 【プライム/医薬品】 売上高:11706110 当期純利益:3873170 総資産:22083700 時価:113638億円

株価

日付初値高値安値終値出来高出来高比前日比upvlogic抽出5%日数高値下落底値上昇
202508256,2666,2716,1956,2102,890,300-248,00099%▼▼▼▼888851984%2%
202509056,4496,6156,4346,6152,313,600-554,200101%▲▲2882510100%10%
202509096,7396,8696,6966,7403,964,3001,031,900101%▲▲▲▲1111410100%12%
202509086,6576,7436,6306,6782,932,400618,800101%▲▲▲1111410100%11%
202508196,3056,5456,3016,5396,506,2003,595,200104%▲▲▲1111401588%7%
202508226,3096,3136,2316,2703,138,300-535,800100%▼▼▼8888241284%3%
202508266,2006,2226,0026,0115,666,9002,776,60097%▼▼▼▼▼777724581%0%
202509186,7846,8806,7246,7682,634,000483,300101%111100100%13%
202508186,2886,3036,2216,2602,911,000-671,900100%▲▲222201584%3%
202509176,7116,7356,6126,7222,150,70099,700100%771700100%12%
202509166,6426,7696,6206,7402,051,000-1,098,800101%▲▲288200100%12%
202509126,7006,7416,6396,6993,149,8001,246,400101%11110099%11%
202509116,6006,6916,5856,6461,903,400-786,700100%▼▼88880099%11%
202509106,7286,7986,6596,6592,690,100-1,274,20099%88880099%11%
202509046,5446,5956,5006,5802,867,800444,100102%11110089%9%
202509036,4886,5146,4186,4442,423,700-181,10099%▼▼88880087%7%
202509026,5256,5306,4416,5082,604,800-397,000100%88280088%8%
202509016,5206,7026,4986,5203,001,800-878,600100%▲▲▲▲22820088%8%
202508296,5456,6196,4846,5093,880,400-570,200100%▲▲▲22220088%8%
202508286,3996,5036,3466,4804,450,600-6,408,900102%▲▲22220987%8%
202508276,2076,4496,1536,38010,859,5005,192,600106%11110486%6%
202508216,4416,4486,2936,3003,674,100-1,379,80098%▼▼888802085%3%
202508206,4486,4606,3236,4355,053,900-1,452,30098%82280087%6%

    TDNET

    strdate時間企業名タイトルurl
    2025072414:00中外薬エフ・ホフマン・ラ・ロシュの2025年中間決算発表について
    2025072416:00中外薬2025年12月期第2四半期(中間期)決算短信〔IFRS〕(連結)
    2025072416:00中外薬2025年12月期第2四半期(中間期)連結決算〔IFRS〕補足資料
    2025072416:00中外薬TOP I 2030実現に向けた医薬品製法開発機能の強化および環境対策推進を目的に新たな研究棟(UKX)の建設を決定
    2025080808:00中外薬経口GLP-1受容体作動薬orforglipronに関するEli Lilly社の発表について
    2025082708:00中外薬経口GLP-1受容体作動薬orforglipronに関するEli Lilly社の発表について
    2025091723:30中外薬経口GLP-1受容体作動薬orforglipronに関するEli Lilly社の発表について

      機関空売り

        信用取引

        日付買残ALL売残ALL一般買残一般売残制度買残制度売残
        2025-08-222,617,90033,8001,004,90010,2001,613,00023,600
        2025-08-292,452,70065,000946,90014,0001,505,80051,000
        2025-09-051,864,60051,700586,70013,5001,277,90038,200
        2025-09-121,673,60049,500548,40012,9001,125,20036,600

          EDINET